[1]
|
Kitabchi, A.E., Umpierrez, G.E., Miles, J.M. and Fisher, J.N. (2009) Hyperglycemic Crises in Adult Patients with Diabetes. Diabetes Care, 32, 1335-1343. https://doi.org/10.2337/dc09-9032
|
[2]
|
Nosadini, R., Velussi, M. and Fioretto, P. (1988) Frequency of Hypoglycaemic and Hyperglycaemic Ketotic Episodes during Conventional and Subcutaneous Continuous Insulin Infusion Therapy in NIDDM. Diabetes Nutrition & Metabolism, 1, 289-298.
|
[3]
|
Kitabchi, A.E., Fisher, J.N., Burghen, G.A., et al. (1982) Problems Associated with Continuous Subcutaneous Insulin Infusion. Hormone and Metabolic Research. SUPPLEMENT Series, 12, 271-276.
|
[4]
|
Teutsch, S.M., Herman, W.H., Dwyer, D.M. and Lane, J.M. (1984) Mortality among Diabetic Patients Using Continuous Subcutaneous Insulin-Infusion Pumps. The New England Journal of Medicine, 310, 361-368. https://doi.org/10.1056/NEJM198402093100606
|
[5]
|
No Authors Listed (1995) Implementation of Treatment Protocols in the Diabetes Control and Complications Trial. Diabetes Care, 18, 361-376. https://doi.org/10.2337/diacare.18.3.361
|
[6]
|
Ponder, S.W., Skyler, J.S., Kruger, D.F., et al. (2008) Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion: Evaluation and Treatment. The Diabetes Educator 34, 327-333. https://doi.org/10.1177/0145721708315682
|
[7]
|
Scrimgeour, L., Cobry, E., McFann, K., et al. (2007) Improved Glycemic Control after Long-Term Insulin Pump Use in Pediatric Patients with Type 1 Diabetes. Diabetes Technology & Therapeutics, 9, 421-428. https://doi.org/10.1089/dia.2007.0214
|
[8]
|
Garg, S.K., Walker, A.J., Ho, H.K., et al. (2004) Glycemic Parameters with Multiple Daily Injections Using Insulin Glargine versus Insulin Pump. Diabetes Technology & Therapeutics, 6, 9-15. https://doi.org/10.1089/152091504322783350
|
[9]
|
Walter, H., Günther, A., Timmler, R. and Mehnert, H. (1989) Ketoacidosis in Long-Term Therapy with Insulin Pumps. Incidence, Causes, Circumstances. Medizinische Klinik (Munich), 84, 565-568. (In German)
|
[10]
|
Blackman, S.M., Raghinaru, D., Adi, S., et al. (2014) Insulin Pump Use in Young Children in the T1D Exchange Clinic Registry Is Associated with Lower Hemoglobin A1c Levels than Injection Therapy. Pediatric Diabetes, 15, 564-572. https://doi.org/10.1111/pedi.12121
|
[11]
|
Bonadio, W. (2013) Pediatric Diabetic Ketoacidosis: An Outpatient Perspective on Evaluation and Management. Pediatric Emergency Medicine Practice, 10, 1-13.
|
[12]
|
Realsen, J., Goettle, H. and Chase, H.P. (2012) Morbidity and Mortality of Diabetic Ketoacidosis with and without Insulin Pump Care. Diabetes Technology & Therapeutics, 14, 1149-1154. https://doi.org/10.1089/dia.2012.0161
|
[13]
|
Rewers, A. (2012) Current Concepts and Controversies in Prevention and Treatment of Diabetic Ketoacidosis in Children. Current Diabetes Reports, 12, 524-532. https://doi.org/10.1007/s11892-012-0307-2
|
[14]
|
Cope, J.U., Samuels-Reid, J.H. and Morrison, A.E. (2012) Pediatric Use of Insulin Pump Technology: A Retrospective Study of Adverse Events in Children Ages 1-12 Years. Journal of Diabetes Science and Technology, 6, 1053-1059. https://doi.org/10.1177/193229681200600509
|
[15]
|
Hanas, R., Lindgren, F. and Lindblad, B. (2009) A 2-yr National Population Study of Pediatric Ketoacidosis in Sweden: Predisposing Conditions and Insulin Pump Use. Pediatric Diabetes, 10, 33-37. https://doi.org/10.1111/j.1399-5448.2008.00441.x
|
[16]
|
Kabadi, U.M. (2013) How Low Do We Fall to Lower Hemoglobin A1c? SGLT2 Inhibitors: Effective Drugs or Expensive Toxins! Journal of Diabetes Mellitus, 3, 199-201. https://doi.org/10.4236/jdm.2013.34030
|
[17]
|
Benoit, S.R., Zhang, Y., Geiss, L.S., Gregg, E.W. and Albright, A. (2018) Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality—United States, 2000-2014. Morbidity and Mortality Weekly Report, 67, 362-365. https://doi.org/10.15585/mmwr.mm6712a3
|
[18]
|
Westphal, S.A. (1996) The Occurrence of Diabetic Ketoacidosis in Non-Insulin-Dependent Diabetes and Newly Diagnosed Diabetic Adults. The American Journal of Medicine, 101, 19-24. https://doi.org/10.1016/S0002-9343(96)00076-9
|
[19]
|
Newton, C.A. and Raskin, P. (2004) Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences. Archives of Internal Medicine, 164, 1925-1931. https://doi.org/10.1001/archinte.164.17.1925
|
[20]
|
Banerji, M.A., Chaiken, R.L., Huey, H., et al. (1994) GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4. Flatbush Diabetes. Diabetes, 43, 741-745. https://doi.org/10.2337/diab.43.6.741
|
[21]
|
Wang, Z.H., Kihl-Selstam, E. and Eriksson, J.W. (2008) Ketoacidosis Occurs in Both Type 1 and Type 2 Diabetes—A Population-Based Study from Northern Sweden. Diabetic Medicine, 25, 867-870. https://doi.org/10.1111/j.1464-5491.2008.02461.x
|
[22]
|
Akhter, J., Jabbar, A., Islam, N. and Khan, M.A. (1993) Diabetic Ketoacidosis in a Hospital Based Population in Pakistan. Journal of Pakistan Medical Association, 43, 137-139.
|
[23]
|
Rosenbloom, A.L. (1990) Intracerebral Crises during Treatment of Diabetic Ketoacidosis. Diabetes Care, 13, 22-33. https://doi.org/10.2337/diacare.13.1.22
|
[24]
|
Marcin, J.P., Glaser, N., Barnett, P., et al. (2002) Factors Associated with Adverse Outcomes in Children with Diabetic Ketoacidosis-Related Cerebral Edema. The Journal of Pediatrics, 141, 793-797. https://doi.org/10.1067/mpd.2002.128888
|
[25]
|
Steenkamp, D.W., Alexanian, S.M. and Mcdonnell, M.E. (2013) Adult Hyperglycemic Crisis: A Review and Perspective. Current Diabetes Reports, 13, 130-137. https://doi.org/10.1007/s11892-012-0342-z
|
[26]
|
Hanas, R., Lindgren, F. and Lindblad, B. (2007) Diabetic Ketoacidosis and Cerebral Oedema in Sweden—A 2-Year Paediatric Population Study. Diabetic Medicine, 24, 1080-1085. https://doi.org/10.1111/j.1464-5491.2007.02200.x
|
[27]
|
Chen, H.F., Wang, C.Y., Lee, H.Y., et al. (2010) Short-Term Case Fatality Rate and Associated Factors among Inpatients with Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Hospital-Based Analysis over a 15-Year Period. Internal Medicine, 49, 729-737. https://doi.org/10.2169/internalmedicine.49.2965
|
[28]
|
MacIsaac, R.J., Lee, L.Y., McNeil, K.J., et al. (2002) Influence of Age on the Presentation and Outcome of Acidotic and Hyperosmolar Diabetic Emergencies. Internal Medicine Journal, 32, 379-385. https://doi.org/10.1046/j.1445-5994.2002.00255.x
|
[29]
|
Holman, R.C., Herron, C.A. and Sinnock, P. (1983) Epidemiologic Characteristics of Mortality from Diabetes with Acidosis or Coma, United States, 1970-78. American Journal of Public Health, 73, 1169-1173. https://doi.org/10.2105/AJPH.73.10.1169
|
[30]
|
Malone, M.L., Gennis, V. and Goodwin, J.S. (1992) Characteristics of Diabetic Ketoacidosis in Older versus Younger Adults. Journal of the American Geriatrics Society, 40, 1100-1104. https://doi.org/10.1111/j.1532-5415.1992.tb01797.x
|
[31]
|
Fayfman, M., Pasquel, F.J. and Umpierrez, G.E. (2017) Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Medical Clinics of North America, 101, 587-606. https://doi.org/10.1016/j.mcna.2016.12.011
|
[32]
|
Huang, C.C., Chien, T.W., Su, S.B., et al. (2013) Infection, Absent Tachycardia, Cancer History, and Severe Coma Are Independent Mortality Predictors in Geriatric Patients with Hyperglycemic Crises. Diabetes Care, 36, e151-e152. https://doi.org/10.2337/dc12-2334
|
[33]
|
Pasquel, F.J., Tsegka, K., Wang, H., et al. (2020) Clinical Outcomes in Patients with Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. Diabetes Care, 43, 349-357. https://doi.org/10.2337/dc19-1168
|
[34]
|
Miles, J.M., Rizza, R.A., Haymond, M.W. and Gerich, J.E. (1980) Effects of Acute Insulin Deficiency on Glucose and Ketone Body Turnover in Man: Evidence for the Primacy of Overproduction of Glucose and Ketone Bodies in the Genesis of Diabetic Ketoacidosis. Diabetes, 29, 926-930. https://doi.org/10.2337/diab.29.11.926
|
[35]
|
Masharani, U., Gitelman, S.E. and Long, R.K. (2017) Hypoglycemic Disorders. In: Gardner, D.G. and Shoback, D., Eds., Greenspan’s Basic & Clinical Endocrinology, McGraw Hill, New York. https://accessmedicine.mhmedical.com/content.aspx?bookid=2178§ionid=166252794
|
[36]
|
McGarry, J.D. (1979) Lilly Lecture 1978. New Perspectives in the Regulation of Ketogenesis. Diabetes, 28, 517-523. https://doi.org/10.2337/diab.28.5.517
|
[37]
|
Defronzo, R.A., Cooke, C.R., Andres, R., et al. (1975) The Effect of Insulin on Renal Handling of Sodium, Potassium, Calcium, and Phosphate in Man. Journal of Clinical Investigation, 55, 845-855. https://doi.org/10.1172/JCI107996
|
[38]
|
Howard, R.L., Bichet, D.G. and Shrier, R.W. (1992) Hypernatremic and Polyuric States. In: Alpern, R., Caplan, M. and Moe, O., Eds., The Kidney: Physiology and Pathophysiology, Raven, New York, 1239-1240+1248+2089.
|
[39]
|
Defronzo, R.A., Goldberg, M. and Agus, Z.S. (1976) The Effects of Glucose and Insulin on Renal Electrolyte Transport. Journal of Clinical Investigation, 58, 83-90. https://doi.org/10.1172/JCI108463
|
[40]
|
Porterfield, D.S., Hinnant, L., Stevens, D.M. and Moy, E. (2010) The Diabetes Primary Prevention Initiative Interventions Focus Area: A Case Study and Recommendations. American Journal of Preventive Medicine, 39, 235-242. https://doi.org/10.1016/j.amepre.2010.05.005
|
[41]
|
LaGasse, J.M., Brantle, M.S., Leech, N.J., et al. (2002) Successful Prospective Prediction of Type 1 Diabetes in Schoolchildren through Multiple Defined Autoantibodies: An 8-Year Follow-Up of the Washington State Diabetes Prediction Study. Diabetes Care, 25, 505-511. https://doi.org/10.2337/diacare.25.3.505
|
[42]
|
Maclaren, N.K., Lan, M.S., Schatz, D., et al. (2003) Multiple Autoantibodies as Predictors of Type 1 Diabetes in a General Population. Diabetologia, 46, 873-874. https://doi.org/10.1007/s00125-003-1123-7
|
[43]
|
Knip, M., Korhonen, S., Kulmala, P., et al. (2010) Prediction of Type 1 Diabetes in the General Population. Diabetes Care, 33, 1206-1212. https://doi.org/10.2337/dc09-1040
|
[44]
|
Ziegler, A.G., Rewers, M., Simell, O., et al. (2013) Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children. JAMA, 309, 2473-2479. https://doi.org/10.1001/jama.2013.6285
|
[45]
|
Steck, A.K., Vehik, K., Bonifacio, E., et al. (2015) Predictors of Progression from the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care, 38, 808-813. https://doi.org/10.2337/dc14-2426
|
[46]
|
Dhatariya, K. (2016) Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. The Review of Diabetic Studies, 13, 217-225. https://doi.org/10.1900/RDS.2016.13.217
|
[47]
|
Adeleye, O.O., Ogbera, A.O., Fasanmade, O., et al. (2012) Latent Autoimmune Diabetes Mellitus in Adults (LADA) and Its Characteristics in a Subset of Nigerians Initially Managed for Type 2 Diabetes. International Archives of Medicine, 5, 23. https://doi.org/10.1186/1755-7682-5-23
|
[48]
|
Nambam, B., Aggarwal, S. and Jain, A. (2010) Latent Autoimmune Diabetes in Adults: A Distinct But Heterogeneous Clinical Entity. World Journal of Diabetes, 1, 111-115. https://doi.org/10.4239/wjd.v1.i4.111
|
[49]
|
Appel, S.J., Wadas, T.M., Rosenthal, R.S. and Ovalle, F. (2009) Latent Autoimmune Diabetes of Adulthood (LADA): An Often Misdiagnosed Type of Diabetes Mellitus. Journal of the American Association of Nurse Practitioners, 21, 156-159. https://doi.org/10.1111/j.1745-7599.2009.00399.x
|
[50]
|
Arikan, E., Sabuncu, T., Ozer, E.M. and Hatemi, H. (2005) The Clinical Characteristics of Latent Autoimmune Diabetes in Adults and Its Relation with Chronic Complications in Metabolically Poor Controlled Turkish Patients with Type 2 Diabetes Mellitus. Journal of Diabetic Complications, 19, 254-258. https://doi.org/10.1016/j.jdiacomp.2005.02.004
|
[51]
|
Monge, L., Bruno, G., Pinach, S., et al. (2004) A Clinically Orientated Approach Increases the Efficiency of Screening for Latent Autoimmune Diabetes in Adults (LADA) in a Large Clinic-Based Cohort of Patients with Diabetes Onset over 50 Years. Diabetic Medicine, 21, 456-459. https://doi.org/10.1111/j.1464-5491.2004.01177.x
|
[52]
|
TFeingold, K.R. (2019) Atypical Forms of Diabetes. In: Feingold, K.R., Anawalt, B., Boyce, A., et al., Eds., Endotext. South Dartmouth (MA): MDText.com.
|
[53]
|
Gordon, E.E. and Kabadi, U.M. (1976) The Hyperglycemic Hyperosmolar Syndrome. The American Journal of the Medical Sciences, 271, 252-268. https://doi.org/10.1097/00000441-197605000-00001
|
[54]
|
Evans, K. (2019) Diabetic Ketoacidosis: Update on Management. Clinical Medicine, 19, 396-398. https://doi.org/10.7861/clinmed.2019-0284
|
[55]
|
McGuire, L.C., Cruickshank, A.M. and Munro, P.T. (2006) Alcoholic Ketoacidosis. Emergency Medicine Journal, 23, 417-420. https://doi.org/10.1136/emj.2004.017590
|
[56]
|
Mihai, B., Lacatusu, C. and Graur, M. (2008) Alcoholic Ketoacidosis. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 112, 321-326.
|
[57]
|
Kabadi, U.M. (1994) Pancreatic Ketoacidosis: Imitator of Diabetic Ketoacidosis! Diabetes Bulletin. International Journal of Diabetes in Developing Countries, 14, 74-77.
|
[58]
|
Kabadi, U.M. (1995) Pancreatic Ketoacidosis: Ketonemia Associated with Acute Pancreatitis. Postgraduate Medical Journal, 71, 32-35. https://doi.org/10.1136/pgmj.71.831.32
|
[59]
|
Alfred, A.V. and Asghar, R. (2014) Use of Anion Gap in Evaluation of a Patient with Metabolic Acidosis. The American Journal of Kidney Diseases, 64, 653-657. https://doi.org/10.1053/j.ajkd.2014.05.022
|
[60]
|
Rice, M., Ismail, B. and Pillow, T. (2014) Approach to Metabolic Acidosis in the Emergency Department. Emergency Medicine Clinics, 32, 403-420. https://doi.org/10.1016/j.emc.2014.01.002
|
[61]
|
DeFronzo, R.A., Matzuda, M. and Barret, E. (1994) Diabetic Ketoacidosis: A Combined Metabolic-Nephrologic Approach to Therapy. Diabetes Review, 2, 209-238.
|
[62]
|
Hillman, K. (1987) Fluid Resuscitation in Diabetic Emergencies—A Reappraisal. Intensive Care Medicine, 13, 4-8. https://doi.org/10.1007/BF00263548
|
[63]
|
Dhatariya, K.K. (2007) Diabetic Ketoacidosis. BMJ, 334, 1284-1285. https://doi.org/10.1136/bmj.39237.661111.80
|
[64]
|
Van zyl, D.G., Rheeder, P. and Delport, E. (2012) Fluid Management in Diabetic-Acidosis—Ringer’s Lactate versus Normal Saline: A Randomized Controlled Trial. QJM, 105, 337-343. https://doi.org/10.1093/qjmed/hcr226
|
[65]
|
Fisher, J.N., Shahshahani, M.N. and Kitabchi, A.E. (1977) Diabetic Ketoacidosis: Low-Dose Insulin Therapy by Various Routes. The New England Journal of Medicine, 297, 238-241. https://doi.org/10.1056/NEJM197708042970502
|
[66]
|
Felig, P., Sherwin, R.S., Soman, V., et al. (1979) Hormonal Interactions in the Regulation of Blood Glucose. Recent Progress in Hormone Research, 35, 501-532. https://doi.org/10.1016/B978-0-12-571135-7.50016-3
|
[67]
|
Umpierrez, G.E., Jones, S., Smiley, D., et al. (2009) Insulin Analogs versus Human Insulin in the Treatment of Patients with Diabetic Ketoacidosis: A Randomized Controlled Trial. Diabetes Care, 32, 1164-1169. https://doi.org/10.2337/dc09-0169
|
[68]
|
Jahagirdar, R.R., Khadilkar, V.V., Khadilkar, A.V. and Lalwani, S.K. (2007) Management of Diabetic Ketoacidosis in PICU. Indian Journal of Pediatrics, 74, 551-554. https://doi.org/10.1007/s12098-007-0106-y
|
[69]
|
Gouin, P.E., Gossain, V.V. and Rovner, D.R. (1985) Diabetic Ketoacidosis: Outcome in a Community Hospital. Southern Medical Journal, 78, 941-943. https://doi.org/10.1097/00007611-198508000-00012
|
[70]
|
Barrios, E.K., Hageman, J., Lyons, E., et al. (2012) Current Variability of Clinical Practice Management of Pediatric Diabetic Ketoacidosis in Illinois Pediatric Emergency Departments. Pediatric Emergency Care, 28, 1307-1313. https://doi.org/10.1097/PEC.0b013e3182768bfc
|
[71]
|
Umpierrez, G.E., Cuervo, R., Karabell, A., et al. (2004) Treatment of Diabetic Ketoacidosis with Subcutaneous Insulin Aspart. Diabetes Care, 27, 1873-1878. https://doi.org/10.2337/diacare.27.8.1873
|
[72]
|
Ersöz, H.O., Ukinc, K., Köse, M., et al. (2006) Subcutaneous Lispro and Intravenous Regular Insulin Treatments Are Equally Effective and Safe for the Treatment of Mild and Moderate Diabetic Ketoacidosis in Adult Patients. International Journal of Clinical Practice, 60, 429-433. https://doi.org/10.1111/j.1368-5031.2006.00786.x
|
[73]
|
Goyal, N., Miller, J.B., Sankey, S.S. and Mossallam, U. (2010) Utility of Initial Bolus Insulin in the Treatment of Diabetic Ketoacidosis. Journal of Emergency Medicine, 38, 422-427. https://doi.org/10.1016/j.jemermed.2007.11.033
|
[74]
|
Kitabchi, A.E., Murphy, M.B., Spencer, J., et al. (2008) Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis? Diabetic Care, 31, 2081-2085. https://doi.org/10.2337/dc08-0509
|
[75]
|
Wagner, A., Risse, A., Brill, H.L., et al. (1999) Therapy of Severe Diabetic Ketoacidosis. Zero-Mortality under Very-Low-Dose Insulin Application. Diabetes Care, 22, 674-677. https://doi.org/10.2337/diacare.22.5.674
|
[76]
|
Bradley, P. and Tobias, J.D. (2007) Serum Glucose Changes during Insulin Therapy in Pediatric Patients with Diabetic Ketoacidosis. American Journal of Therapeutics, 14, 265-268. https://doi.org/10.1097/01.mjt.0000209687.52571.65
|
[77]
|
Mudaliar, S., Mohideen, P., Deutsch, R., et al. (2002) Intravenous Glargine and Regular Insulin Have Similar Effects on Endogenous Glucose Output and Peripheral Activation/Deactivation Kinetic Profiles. Diabetes Care, 25, 1597-602. https://doi.org/10.2337/diacare.25.9.1597
|
[78]
|
Nyenwe, E.A. and Kitabchi, A.E. (2016) The Evolution of Diabetic Ketoacidosis: An Update of Its Etiology, Pathogenesis and Management. Metabolism, 65, 507-521. https://doi.org/10.1016/j.metabol.2015.12.007
|
[79]
|
Kabadi, U.M. (2011) Iowa Medicaid 2: Lapse of Glycemic Control on Abrupt Transition from Insulin Glargine to Insulin Detemir in Type 2 Diabetes Mellitus. Journal of Diabetes Mellitus, 1, 124-129. https://doi.org/10.4236/jdm.2011.14017
|
[80]
|
Kabadi, U.M. (2008) Starting Insulin in Type 2 Diabetes: Overcoming Barriers to Insulin Therapy. International Journal of Diabetes in Developing Countries, 28, 65-68. https://doi.org/10.4103/0973-3930.43102
|
[81]
|
Kabadi, U.M. and Raman, R. (2005) Insulin Therapy. Primary Care Reports No. 11, 109-120.
|
[82]
|
Eastman, D.K., Bottenberg, M.M., Hegge, K.A., et al. (2009) Intensive Insulin Therapy in Critical Care Settings. Current Clinical Pharmacology, 4, 71-77. https://doi.org/10.2174/157488409787236100
|
[83]
|
Tricco, A.C., Ashoor, H.M., Antony, J., et al. (2014) Safety, Effectiveness, and Cost Effectiveness of Long Acting versus Intermediate Acting Insulin for Patients with Type 1 Diabetes: Systematic Review and Network Meta-Analysis. BMJ, 349, g5459. https://doi.org/10.1136/bmj.g5459
|
[84]
|
Plank, J., Bodenlenz, M., Sinner, F., et al. (2005) A Double-Blind, Randomized, Dose-Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin Analog Detemir. Diabetes Care, 28, 1107-1112. https://doi.org/10.2337/diacare.28.5.1107
|
[85]
|
Porcellati, F., Rossetti, P., Busciantella, N.R., et al. (2007) Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A Double-Blind, Randomized, Crossover Study. Diabetes Care, 30, 2447-2452. https://doi.org/10.2337/dc07-0002
|
[86]
|
Laubner, K., Molz, K., Kerner, W., et al. (2014) Daily Insulin Doses and Injection Frequencies of Neutral Protamine Hagedorn (NPH) Insulin, Insulin Detemir and Insulin Glargine in Type 1 and Type 2 Diabetes: A Multi-Center Analysis of 51964 Patients from the German/Austrian DPV-Wiss Database. Diabetes/Metabolism Research and Reviews, 30, 395-404. https://doi.org/10.1002/dmrr.2500
|
[87]
|
Kabadi, U.M. (2008) Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus. Clinical Drug Investigation, 28, 697-701. https://doi.org/10.2165/00044011-200828110-00003
|
[88]
|
Wilson, H.K., Keuer, S.P., Lea, A.S., et al. (1982) Phosphate Therapy in Diabetic Ketoacidosis. Archives of Internal Medicine, 142, 517-520. https://doi.org/10.1001/archinte.1982.00340160097021
|
[89]
|
Chua, H.R., Schneider, A. and Bellomo, R. (2011) Bicarbonate in Diabetic Ketoacidosis—A Systematic Review. Annals of Intensive Care, 1, 23. https://doi.org/10.1186/2110-5820-1-23
|
[90]
|
Duhon, B., Attridge, R.L., Franco-Martinez, A.C., et al. (2013) Intravenous Sodium Bicarbonate Therapy in Severely Acidotic Diabetic Ketoacidosis. Annals of Pharmacotherapy, 47, 970-975. https://doi.org/10.1345/aph.1S014
|
[91]
|
Kitabchi, A.E., Umpierrez, G.E., Fisher, J.N., et al. (2008) Thirty Years of Personal Experience in Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. The Journal of Clinical Endocrinology & Metabolism, 93, 1541-1552. https://doi.org/10.1210/jc.2007-2577
|
[92]
|
Young, M.C. (1995) Simultaneous Acute Cerebral and Pulmonary Edema Complicating Diabetic Ketoacidosis. Diabetes Care, 18, 1288-1290. https://doi.org/10.2337/diacare.18.9.1288
|
[93]
|
Carroll, P. and Matz, R. (1982) Adult Respiratory Distress Syndrome Complicating Severely Uncontrolled Diabetes Mellitus: Report of Nine Cases and a Review of Literature. Diabetes Care, 5, 574-580. https://doi.org/10.2337/diacare.5.6.574
|
[94]
|
The Big Picture (2021) Checking Your Blood Sugar. Blood Sugar Testing and Control. American Diabetes Association. https://www.diabetes.org/healthy-living/medication-treatments/blood-glucose-testing-and-control/checking-your-blood-sugar
|
[95]
|
Byrne, H.A., Tieszen, K.L., Hollis, S., et al. (2000) Evaluation of an Electrochemical Sensor for Measuring Blood Ketones. Diabetes Care, 23, 500-503. https://doi.org/10.2337/diacare.23.4.500
|
[96]
|
Weber, C., Kocher, S., Neeser, K. and Joshi, S.R. (2009) Prevention of Diabetic Ketoacidosis and Self-Monitoring of Ketone Bodies: An Overview. Current Medical Research and Opinion, 25, 1197-1207. https://doi.org/10.1185/03007990902863105
|
[97]
|
American Diabetes Association (2015) Standards of Medical Care in Diabetes. Diabetes Care, 38, 37.
|